Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Davila

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Immunological Reviews|July 10, 2004
Computational tools for understanding sequence variability in recombination signalsLindsay G Cowell, Marco Davila, Dale Ramsden, et al.
Genome Biology|January 23, 2003
Identification and utilization of arbitrary correlations in models of recombination signal sequencesLindsay G Cowell, Marco Davila, Thomas B Kepler, et al.
BMC Immunology|June 27, 2009
Conserved cryptic recombination signals in Vkappa gene segments are cleaved in small pre-B cellsAnne E Lieberman, Masayuki Kuraoka, Marco Davila, et al.
The Journal of Experimental Medicine|January 23, 2003
Prospective estimation of recombination signal efficiency and identification of functional cryptic signals in the genome by statistical modelingLindsay G Cowell, Marco Davila, Kaiyong Yang, et al.
Journal of Visualized Experiments : Jove|October 11, 2021
Expansion and Enrichment of Gamma-Delta (γδ) T Cells from Apheresed Human ProductAna Marie Landin, Cheryl Cox, Bin Yu, et al.
JCO Clinical Cancer Informatics|March 20, 2026
Cost-Effectiveness of Maintaining Higher Stem-Cell Collection Thresholds in the Chimeric Antigen Receptor T-Cell Era for Multiple MyelomaEhsan Malek, Brian Betts, Megan Herr, et al.
The Journal of Experimental Medicine|December 7, 2007
Multiple, conserved cryptic recombination signals in VH gene segments: detection of cleavage products only in pro B cellsMarco Davila, Feifei Liu, Lindsay G Cowell, et al.
The New England Journal of Medicine|February 1, 2018
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic LeukemiaJae H Park, Isabelle Rivière, Mithat Gonen, et al.
Leukemia & Lymphoma|November 13, 2025
Analysis of epidemiologic factors and treatment effects on immunophenotypes in hematologic malignancy patientsTheresa Hahn, Megan M Herr, Paul K Wallace, et al.
Transplantation and Cellular Therapy|November 9, 2025
Recommendations for Defining Chimeric Antigen Receptor T-Cell (CAR T) Dose-Limiting Toxicities (DLTs) for Future Early-Phase CAR T Therapy StudiesFrederick L Locke, Sarah Nikiforow, Matthew J Frigault, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Immunological Reviews|July 10, 2004
Computational tools for understanding sequence variability in recombination signalsLindsay G Cowell, Marco Davila, Dale Ramsden, et al.
Genome Biology|January 23, 2003
Identification and utilization of arbitrary correlations in models of recombination signal sequencesLindsay G Cowell, Marco Davila, Thomas B Kepler, et al.
BMC Immunology|June 27, 2009
Conserved cryptic recombination signals in Vkappa gene segments are cleaved in small pre-B cellsAnne E Lieberman, Masayuki Kuraoka, Marco Davila, et al.
The Journal of Experimental Medicine|January 23, 2003
Prospective estimation of recombination signal efficiency and identification of functional cryptic signals in the genome by statistical modelingLindsay G Cowell, Marco Davila, Kaiyong Yang, et al.
Journal of Visualized Experiments : Jove|October 11, 2021
Expansion and Enrichment of Gamma-Delta (γδ) T Cells from Apheresed Human ProductAna Marie Landin, Cheryl Cox, Bin Yu, et al.
JCO Clinical Cancer Informatics|March 20, 2026
Cost-Effectiveness of Maintaining Higher Stem-Cell Collection Thresholds in the Chimeric Antigen Receptor T-Cell Era for Multiple MyelomaEhsan Malek, Brian Betts, Megan Herr, et al.
The Journal of Experimental Medicine|December 7, 2007
Multiple, conserved cryptic recombination signals in VH gene segments: detection of cleavage products only in pro B cellsMarco Davila, Feifei Liu, Lindsay G Cowell, et al.
The New England Journal of Medicine|February 1, 2018
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic LeukemiaJae H Park, Isabelle Rivière, Mithat Gonen, et al.
Leukemia & Lymphoma|November 13, 2025
Analysis of epidemiologic factors and treatment effects on immunophenotypes in hematologic malignancy patientsTheresa Hahn, Megan M Herr, Paul K Wallace, et al.
Transplantation and Cellular Therapy|November 9, 2025
Recommendations for Defining Chimeric Antigen Receptor T-Cell (CAR T) Dose-Limiting Toxicities (DLTs) for Future Early-Phase CAR T Therapy StudiesFrederick L Locke, Sarah Nikiforow, Matthew J Frigault, et al.
Pageof 3